The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response (Q56994857)

5

0 references

Rita Vanbever

6

object named as

Rita Vanbever

0 references

author name string

Antoine Minne

1

0 references

Jamila Louahed

2

0 references

Sybille Mehauden

3

0 references

Benoît Baras

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

4

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

Immunology

0 references

volume

122

0 references

page(s)

316-25

0 references

issue

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

The unmet need in the elderly: designing new influenza vaccines for older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Anatomical features of anti-viral immunity in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Cytokines induce the development of functionally heterogeneous T helper cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Role of secretory antibodies in the defence against infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02641.X

Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Vaccination by aerosols: modulation of clearance mechanisms in the lung

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Viral vaccination via the mucosal routes.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Serious morbidity and mortality associated with influenza epidemics

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Clearance of different-sized proteins from the alveolar space in humans and rabbits

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2266027

Nasal mucociliary clearance as a factor in nasal drug delivery

2 November 2018

1 reference

12 December 2020

Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine

1 reference

12 December 2020

Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers

1 reference

12 December 2020

Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects

1 reference

12 December 2020

Retention of monodisperse or polydisperse aluminosilicate particles inhaled by dogs, rats, and mice

1 reference

12 December 2020

Can needle-free administration of vaccines become the norm in global immunization?

1 reference

12 December 2020

Methodology for the measurement of mucociliary function in the mouse by scintigraphy

1 reference

12 December 2020

Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines

1 reference

12 December 2020

Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract

1 reference

12 December 2020